Technical Analysis for BLU - BELLUS Health Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Historical BLU trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Cup with Handle | Other | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Stochastic Sell Signal | Bearish | -2.65% | |
Inside Day | Range Contraction | -2.65% | |
Wide Bands | Range Expansion | -2.65% | |
Overbought Stochastic | Strength | -2.65% | |
Wide Bands | Range Expansion | -0.23% | |
Overbought Stochastic | Strength | -0.23% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 5% | about 4 hours ago |
Outside Day | about 4 hours ago |
Fell Below Previous Day's Low | about 4 hours ago |
60 Minute Opening Range Breakdown | about 6 hours ago |
Down 3% | about 6 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/12/2021
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics for conditions with high unmet medical need. Its lead drug candidate includes BLU-5937, a small molecule antagonist of the P2X3 receptor for chronic cough. The company also has economic interests in various partnered development stage programs, including KIACTA for the treatment of sarcoidosis; AMO-01 for treatment of Phelan McDermid syndrome; and ALZ-801 for APOE4 homozygous Alzheimer's disease. BELLUS Health Inc. was founded in 1993 and is headquartered in Laval, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Biology Alzheimer's Disease Specialty Drugs Abdominal Pain Cough Mozy Angiotensin Converting Enzyme Chronic Cough
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Biology Alzheimer's Disease Specialty Drugs Abdominal Pain Cough Mozy Angiotensin Converting Enzyme Chronic Cough
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.03 |
52 Week Low | 2.01 |
Average Volume | 1,358,786 |
200-Day Moving Average | 3.10 |
50-Day Moving Average | 4.09 |
20-Day Moving Average | 4.19 |
10-Day Moving Average | 4.47 |
Average True Range | 0.28 |
ADX | 15.39 |
+DI | 16.82 |
-DI | 18.71 |
Chandelier Exit (Long, 3 ATRs ) | 3.88 |
Chandelier Exit (Short, 3 ATRs ) | 4.36 |
Upper Bollinger Band | 4.83 |
Lower Bollinger Band | 3.56 |
Percent B (%b) | 0.66 |
BandWidth | 30.17 |
MACD Line | 0.14 |
MACD Signal Line | 0.12 |
MACD Histogram | 0.0175 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.87 | ||||
Resistance 3 (R3) | 4.87 | 4.73 | 4.79 | ||
Resistance 2 (R2) | 4.73 | 4.61 | 4.72 | 4.76 | |
Resistance 1 (R1) | 4.56 | 4.54 | 4.49 | 4.56 | 4.74 |
Pivot Point | 4.42 | 4.42 | 4.38 | 4.41 | 4.42 |
Support 1 (S1) | 4.25 | 4.30 | 4.18 | 4.25 | 4.06 |
Support 2 (S2) | 4.11 | 4.23 | 4.10 | 4.04 | |
Support 3 (S3) | 3.94 | 4.11 | 4.01 | ||
Support 4 (S4) | 3.94 |